{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:36:29Z","timestamp":1707525389637},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,5]]},"DOI":"10.7759\/cureus.48319","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T02:32:17Z","timestamp":1699237937000},"source":"Crossref","is-referenced-by-count":0,"title":["A Teaching Case: Persistent COVID-19 Pneumonia Resembling Cryptogenic Organizing Pneumonia in a Patient With Remitted Lymphoma"],"prefix":"10.7759","author":[{"given":"Toyoshi","family":"Yanagihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Kadowaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Ishimatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhito","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Moriuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atushi","family":"Moriwaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa446","article-title":"Persistent COVID-19 in an immunocompromised patient temporarily responsive to two courses of remdesivir therapy","volume":"222","author":"Helleberg M","year":"2020","unstructured":"Helleberg M, Niemann CU, Moestrup KS, Kirk O, Lebech AM, Lane C, Lundgren J. Persistent COVID-19 in an immunocompromised patient temporarily responsive to two courses of remdesivir therapy. J Infect Dis. 2020, 222:1103-7. 10.1093\/infdis\/jiaa446","journal-title":"J Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2020.12.001","article-title":"Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient","volume":"27","author":"Nakajima Y","year":"2021","unstructured":"Nakajima Y, Ogai A, Furukawa K, et al.. Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient. J Infect Chemother. 2021, 27:387-9. 10.1016\/j.jiac.2020.12.001","journal-title":"J Infect Chemother"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028470","article-title":"Prolonged viral positivity induced recurrent coronavirus disease 2019 (COVID-19) pneumonia in patients receiving anti-CD20 monoclonal antibody treatment: case reports","volume":"100","author":"Deveci B","year":"2021","unstructured":"Deveci B, Saba R. Prolonged viral positivity induced recurrent coronavirus disease 2019 (COVID-19) pneumonia in patients receiving anti-CD20 monoclonal antibody treatment: case reports. Medicine (Baltimore). 2021, 100:e28470. 10.1097\/MD.0000000000028470","journal-title":"Medicine (Baltimore)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-021-00491-2","article-title":"Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy","volume":"20","author":"Taha Y","year":"2021","unstructured":"Taha Y, Wardle H, Evans AB, et al.. Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy. Ann Clin Microbiol Antimicrob. 2021, 20:85. 10.1186\/s12941-021-00491-2","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1637","article-title":"Sustained response after remdesivir and convalescent plasma therapy in a B-cell-depleted patient with protracted coronavirus disease 2019 (COVID-19)","volume":"73","author":"Malsy J","year":"2021","unstructured":"Malsy J, Veletzky L, Heide J, et al.. Sustained response after remdesivir and convalescent plasma therapy in a B-cell-depleted patient with protracted coronavirus disease 2019 (COVID-19). Clin Infect Dis. 2021, 73:e4020-4. 10.1093\/cid\/ciaa1637","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01175-8","article-title":"Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection","volume":"35","author":"Reuken PA","year":"2021","unstructured":"Reuken PA, Stallmach A, Pletz MW, et al.. Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection. Leukemia. 2021, 35:920-3. 10.1038\/s41375-021-01175-8","journal-title":"Leukemia"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4081\/monaldi.2021.1867","article-title":"Hyperimmune plasma infusion in an immunocompromised Covid-19 patient previously treated for follicular lymphoma","volume":"91","author":"Levi G","year":"2021","unstructured":"Levi G, Rocchetti C, Magri R, et al.. Hyperimmune plasma infusion in an immunocompromised Covid-19 patient previously treated for follicular lymphoma. Monaldi Arch Chest Dis. 2021, 91:10.4081\/monaldi.2021.1867","journal-title":"Monaldi Arch Chest Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab335","article-title":"Successful treatment of persistent coronavirus disease 2019 infection in a patient with hypogammaglobulinemia with REGN-COV2: a case report","volume":"8","author":"Luitel P","year":"2021","unstructured":"Luitel P, Vais D, Gidron A. Successful treatment of persistent coronavirus disease 2019 infection in a patient with hypogammaglobulinemia with REGN-COV2: a case report. Open Forum Infect Dis. 2021, 8:ofab335. 10.1093\/ofid\/ofab335","journal-title":"Open Forum Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.613502","article-title":"Case report: stepwise anti-inflammatory and anti-SARS-CoV-2 effects following convalescent plasma therapy with full clinical recovery","volume":"12","author":"Zimmerli A","year":"2021","unstructured":"Zimmerli A, Monti M, Fenwick C, et al.. Case report: stepwise anti-inflammatory and anti-SARS-CoV-2 effects following convalescent plasma therapy with full clinical recovery. Front Immunol. 2021, 12:613502. 10.3389\/fimmu.2021.613502","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2021.11.018","article-title":"Recovery from severe persistent COVID-19 without evidence of an anti-SARS-CoV-2 antibody response in a man with mantle cell lymphoma treated with rituximab","volume":"28","author":"Horiuchi H","year":"2022","unstructured":"Horiuchi H, Sasaki H, Miyazaki K, Miyata N, Yoshimura Y, Tachikawa N. Recovery from severe persistent COVID-19 without evidence of an anti-SARS-CoV-2 antibody response in a man with mantle cell lymphoma treated with rituximab. J Infect Chemother. 2022, 28:329-32. 10.1016\/j.jiac.2021.11.018","journal-title":"J Infect Chemother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2021.101560","article-title":"Successful treatment of prolonged COVID-19 with Bamlanivimab in a patient with severe B-Cell aplasia due to treatment with an anti-CD20 monoclonal antibody: a case report","volume":"34","author":"Daher A","year":"2021","unstructured":"Daher A, M\u00fcller T, Spiesshoefer J, Dreher M, Panse J. Successful treatment of prolonged COVID-19 with Bamlanivimab in a patient with severe B-Cell aplasia due to treatment with an anti-CD20 monoclonal antibody: a case report. Respir Med Case Rep. 2021, 34:101560. 10.1016\/j.rmcr.2021.101560","journal-title":"Respir Med Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2022.01.014","article-title":"Persistent viral shedding of severe acute respiratory syndrome coronavirus 2 after treatment with bendamustine and rituximab: a case report","volume":"28","author":"Arai T","year":"2022","unstructured":"Arai T, Mukai S, Kazama R, Ogawa Y, Nishida K, Hatanaka K, Gohma I. Persistent viral shedding of severe acute respiratory syndrome coronavirus 2 after treatment with bendamustine and rituximab: a case report. J Infect Chemother. 2022, 28:810-3. 10.1016\/j.jiac.2022.01.014","journal-title":"J Infect Chemother"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2116777","article-title":"Cryptogenic organizing pneumonia","volume":"386","author":"King TE Jr","year":"2022","unstructured":"King TE Jr, Lee JS. Cryptogenic organizing pneumonia. N Engl J Med. 2022, 386:1058-69. 10.1056\/NEJMra2116777","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.20957","article-title":"Effectiveness of casirivimab-imdevimab and sotrovimab during a SARS-CoV-2 Delta variant surge: a cohort study and randomized comparative effectiveness trial","volume":"5","author":"Huang DT","year":"2022","unstructured":"Huang DT, McCreary EK, Bariola JR, et al.. Effectiveness of casirivimab-imdevimab and sotrovimab during a SARS-CoV-2 Delta variant surge: a cohort study and randomized comparative effectiveness trial. JAMA Netw Open. 2022, 5:e2220957. 10.1001\/jamanetworkopen.2022.20957","journal-title":"JAMA Netw Open"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-4307","article-title":"Bronchoalveolar lavage-detected SARS-CoV-2 infection in presence of serial negative nasopharyngeal swabs: a case report","volume":"9","author":"Caci G","year":"2021","unstructured":"Caci G, Minervini F, Fechner C, Roos JE, Obermann EC, Azzola A. Bronchoalveolar lavage-detected SARS-CoV-2 infection in presence of serial negative nasopharyngeal swabs: a case report. Ann Transl Med. 2021, 9:583. 10.21037\/atm-20-4307","journal-title":"Ann Transl Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-021-02714-y","article-title":"Bronchoalveolar lavage in suspected COVID-19 cases with a negative nasopharyngeal swab: a retrospective cross-sectional study in a high-impact Northern Italy area","volume":"16","author":"Barberi C","year":"2021","unstructured":"Barberi C, Castelnuovo E, Dipasquale A, et al.. Bronchoalveolar lavage in suspected COVID-19 cases with a negative nasopharyngeal swab: a retrospective cross-sectional study in a high-impact Northern Italy area. Intern Emerg Med. 2021, 16:1857-64. 10.1007\/s11739-021-02714-y","journal-title":"Intern Emerg Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.3786","article-title":"Detection of SARS-CoV-2 in different types of clinical specimens","volume":"323","author":"Wang W","year":"2020","unstructured":"Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, Tan W. Detection of SARS-CoV-2 in different types of clinical specimens. J Am Med Assoc. 2020, 323:1843-4. 10.1001\/jama.2020.3786","journal-title":"J Am Med Assoc"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202007-868RL","article-title":"Bronchoalveolar lavage in patients with COVID-19 with invasive mechanical ventilation for acute respiratory distress syndrome","volume":"18","author":"Baron A","year":"2021","unstructured":"Baron A, Hachem M, Tran Van Nhieu J, et al.. Bronchoalveolar lavage in patients with COVID-19 with invasive mechanical ventilation for acute respiratory distress syndrome. Ann Am Thorac Soc. 2021, 18:723-6. 10.1513\/AnnalsATS.202007-868RL","journal-title":"Ann Am Thorac Soc"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-03148-w","article-title":"Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia","volume":"590","author":"Grant RA","year":"2021","unstructured":"Grant RA, Morales-Nebreda L, Markov NS, et al.. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia. Nature. 2021, 590:635-41. 10.1038\/s41586-020-03148-w","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.12.040","article-title":"Complement activation induces excessive T cell cytotoxicity in severe COVID-19","volume":"185","author":"Georg P","year":"2022","unstructured":"Georg P, Astaburuaga-Garc\u00eda R, Bonaguro L, et al.. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022, 185:493-512.e25. 10.1016\/j.cell.2021.12.040","journal-title":"Cell"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/202333-a-teaching-case-persistent-covid-19-pneumonia-resembling-cryptogenic-organizing-pneumonia-in-a-patient-with-remitted-lymphoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:08:47Z","timestamp":1707509327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/202333-a-teaching-case-persistent-covid-19-pneumonia-resembling-cryptogenic-organizing-pneumonia-in-a-patient-with-remitted-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,5]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.48319","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,5]]}}}